Session Description: There is growing evidence to support benefits of antidiabetic therapy beyond glycemic lowering. Recent guidelines include consideration of underlying comorbidities including obesity, renal, cardiovascular, and non-alcoholic fatty liver disease in individualizing treatment regimens for our patients. Our colleagues in cardiology and nephrology have also begun to prescribe these medications for risk modification beyond glycemic control. A thorough understanding of the evidence to support recent guidelines is essential to designing treatment regimens to successfully achieve glycemic targets while modifying the risk associated with comorbid conditions.
Faculty: Jennifer Green, MD
Duke University
Learning Objectives:
Return to the full CEU program.
Join us for virtual CEU 2022 on September 8-10 to discover the latest innovative practices in endocrinology diagnosis and treatment. This is a must-attend event for all endocrinologists, and it features 42 sessions covering nine of the most crucial topics in hormone health. CEU is certified for 28 AMA PRA Category 1 Credits™ and AAPA Category 1 CME Credits and Nursing Contact Hours.
Test your knowledge in everyday practice with Endocrine Self-Assessment Program (ESAP™), the premier self-assessment tool for all areas of endocrinology, diabetes, and metabolism. This year’s edition features 120 newly published clinical cases and questions, including a variety of common and rare conditions. Certified for 40.0 AMA PRA Category 1 Credits™ and 40.0 ABIM MOC Points, this product includes access to interactive online modules as well as a printed book to guide your study.
